Professor Tony Green is leading the five-year programme to help increase understanding of myeloproliferative neoplasms (MPNs). MPNs are a group of blood disorders related to leukaemia that cause the normal regulation of blood cell production to break down, which creates too many blood cells and means the blood can become thick.
The Cambridge team will use cutting-edge genetic techniques to analyse tissue samples from MPN patients. This is to establish exactly how faulty genes can dictate how and whether the disease will progress, and how the genetic make-up affects the response to therapy.
Read more: Leukaemia & Lymphoma Research